ArticleFrontiers in immunology2022

An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis.

Styliani Karanika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.